Practitioner-specific medians for nuchal translucency to improve first-trimester screening performance

Obstetrics and Gynecology

Volumn 119, Issue 4, 2012, Pages 785-794

  Wu, Nerissa ^a,b,c   Platt, Lawrence D ^a,b,c   Greene, Naomi ^a,b,c   Currier, Robert J ^a,b,c  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Fetal Medicine Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; CROWN RUMP LENGTH; DATA BASE; DOWN SYNDROME; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; NUCHAL TRANSLUCENCY MEASUREMENT; NUCHAL TRANSLUCENCY MEDIAN; OUTCOME ASSESSMENT; PHYSICIAN; PREDICTIVE VALUE; PRENATAL SCREENING; PRIORITY JOURNAL; RISK ASSESSMENT; TRISOMY 18;

CALIFORNIA; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; NUCHAL TRANSLUCENCY MEASUREMENT; OBSERVER VARIATION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RETROSPECTIVE STUDIES; TRISOMY;

EID: 84859085188     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31824be8f5     Document Type: Article

References (12)

1. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001-11. (Pubitemid 41609093)
2. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 2003;10:56 -104.
3. Snijders RJ, Thom EA, Zachary JM, Platt LD, Greene N, Jackson LG, et al. First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique. Ultrasound Obstet Gynecol 2002;19:353-9. (Pubitemid 34592131)
4. Evans MI, Van Decruyes H, Nicolaides KH. Nuchal translucency measurements for first-trimester screening: the 'price' of inaccuracy. Fetal Diagn Ther 2007;22:401-4. (Pubitemid 350014923)
5. Hadlock FP, Shah YP, Kanon DJ, Math B, Lindsey JV. Fetal crown-rump length: reevaluation of relation to menstrual age (5-18 weeks) with high-resolution real time US. Radiology 1992;182:501-5.
6. California Department of Public Health. The California prenatal screening program: Prenatal care provider handbook. Available at: www.cdph.ca.gov/ programs/pns/Pages/default.aspx. Retrieved December 15, 2011.
7. Palomaki GE, Lee JE, Canick JA, McDowell GA, Donnenfeld AE; ACMG Laboratory Quality Assurance Committee. Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements. Genet Med 2009;11:669-81.
8. Nicolaides KH, Chervenak FA, McCullough LB, Avgidou K, Papageorghiou A. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Am J Obstet Gynecol 2005;193:322-6. (Pubitemid 41159522)
9. Jaques AM, Collins VR, Muggli EE, Amor DJ, Francis I, Sheffield LJ, et al. Uptake of prenatal diagnostic testing and the effectiveness of prenatal screening for Down syndrome. Prenat Diagn 2010;30:522-30.
10. Evans MI, Cuckle HS. Performance adjusted risks: a method to improve the quality of algorithm performance while allowing all to play. Prenat Diag 2011;31:797-801.
11. Canick J. Prenatal screening for trisomy 21: recent advances and guidelines. Clin Chem Lab Med 2011 Jul 27 [Epub ahead of print].
12. Sahota DS, Chen M, Leung TY, Chan LW, Fung TY, Ting YH, et al. Assessment of sonographer nuchal translucency measurement performance - central tendency and dispersion. J Matern Fetal Neonatal Med 2011;24:812-6.